Legend Biotech Corporation
LEGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $3 | $5 | $4 | $3 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $4 | $3 | $3 |
| Revenue | $1 | $0 | $0 | $0 |
| % Growth | 120% | 143.7% | 70% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 62.6% | 49.4% | 44.1% | 100% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -18% | -167.6% | -356% | -570.1% |
| Net Income | -$0 | -$1 | -$0 | -$0 |
| % Margin | -28.2% | -181.8% | -381.5% | -586.4% |
| EPS Diluted | -1.94 | -5.88 | -5.62 | -5.48 |
| % Growth | 67% | -4.6% | -2.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |